期刊文献+

大肠杆菌耐药性抑制剂作用机制的初步研究 被引量:22

Study on molecular mechanisms of drug-resistantinhibitors in Escherichia coli
下载PDF
导出
摘要  20株人源和动物源性大肠杆菌在体外经黄连提取物(命名为耐药性抑制剂IT2)作用后,对氟喹诺酮类抗菌药、庆大霉素和多西环素的耐药性明显被抑制。选取经抑制剂IT2作用后耐药性变化显著的5对菌株进行质粒提取和电泳检测,发现J0、H004、J3、J2等4株菌作用前均有质粒带,与其相对应的耐药性抑制剂作用后的菌株ITJ0、ITH004、ITJ3、ITJ2质粒带全部消失,只有菌株J1经抑制剂IT2作用前后质粒带无变化。提取外膜蛋白进行SDS-PAGE电泳分析,菌株J1、J3、J0缺少OmpF、OmpA,J2仅缺少OmpA,经耐药性抑制剂作用后,J1、J3、J0的OmpF均由缺失恢复为表达,OmpC的表达量呈显著增加,H004没有变化。结果表明耐药性抑制剂IT2对大肠杆菌的部分耐药性具有良好的抑制作用,其作用与阻碍耐药质粒拷贝、恢复外膜通道蛋白正常表达关系密切。 Twenty multi-drug resistant strains of pathogenic E.coli isolated from clinical samples of patients and sick chicken were cultured in LB which contained certain concentration of the extracts of coptis root (named inhibitor IT2). Five pairs of strains(before treatment and after treatment) were selected to be extracted plasmids and outer membrane proteins (OMP) because their characteristics of resistance to fluoquinolones, gentamicin, deoxycycline changed apparently. Detection with agarose electrophoresis, strains J0,H004,J3 and J2 all had resistant plasmids,while strains ITJ0,ITH004,ITJ3,ITJ2 (treated with inhibitor IT2) did not have any plasmids. Only plasmid of strain J1 was not eliminated by inhibitor IT2. SDS-PAGE showed that OMPs of strains J1,J3 and J0 all lacked of OmpF and OmpA, J2 lacked of OmpA. After being treated with IT2, strains J1,J3 and J0 recovered to express OmpF,the quantity of OmpC was increased. There was only strain H004 was not found any changes in OMPs. As a result, inhibition effects of IT2 may be associated with the elimination of resistant plasmids and the recovery of normal expression of OMPs.
出处 《中国兽药杂志》 2004年第2期18-21,共4页 Chinese Journal of Veterinary Drug
基金 国家自然科学基金(30170698)
关键词 大肠杆菌 耐药性 抑制剂 作用机制 质粒 外膜通道蛋白 抗菌药 Escherichia coli drug-resistant inhibitor mechanisms
  • 相关文献

参考文献2

二级参考文献9

  • 1王如治.药剂学(第3版)[M].北京:人民卫生出版社,1997.125-135.
  • 2王如治.药剂学(第3版)[M].北京:人民卫生出版社,1997.125-135.
  • 3Linde H J,Notka F,Metz M. et al.In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the Cterminal part of MarR[J].Antimicrob Agents Chemother, 2000,44(7): 1865-1868.
  • 4Markham P N. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcusaureus[J]. Antimicrob Agents Chemother, 1999,43(10) :2404-2408.
  • 5Dantzig A H. Reversal of Muhidrug Resistance by the P-Glycoprorein Modulator, LY335979, from the Bench to the Clinic[J]. CurtMed Chem, 2001,8(1) :39-50.
  • 6Garuier-suillerot A. Analysis of Drug Transport Kinetics in Multidrug-resistant Cells: Implications for Drug Action C J]. Curr Med Chem, 2001,8( 1 ) :51-64.
  • 7Payen L. The sulphonylurea glibenclamide inhibits muhidrug resistance protein(MRP1) activity in human lung cancer cells [J]. Br J Pharmaco1,2001,132(3) :778-784.
  • 8Nacsa J.The inhibition of SOS-responses and MDR by phenothiafine-metal complexes[J]. Anticancer Res, 1998, 18(4):3093-3O98.
  • 9陈群,王胜春.黄芩和黄连对大肠杆菌R质粒消除作用的实验研究[J].广东医学院学报,1998,16(1):1-3. 被引量:54

共引文献46

同被引文献298

引证文献22

二级引证文献246

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部